Publications by authors named "Qiyan Zheng"

Ethnopharmacological Relevance: The JinChan YiShen TongLuo (JCYSTL) formula, a traditional Chinese medicine (TCM), has been used clinically for decades to treat diabetic nephropathy (DN). TCM believes that the core pathogenesis of DN is "kidney deficiency and collateral obstruction," and JCYSTL has the effect of "tonifying kidney and clearing collateral," thus alleviating the damage to kidney structure and function caused by diabetes. From the perspective of modern medicine, mitochondrial damage is an important factor in DN pathogenesis.

View Article and Find Full Text PDF

Aims: This study aimed to evaluate the effects of hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) on iron metabolism and inflammation in dialysis-dependent chronic kidney disease (DD-CKD) patients.

Methods: PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov websites were searched for randomized controlled trials (RCTs) investigating HIF-PHIs versus ESAs for DD-CKD patients.

View Article and Find Full Text PDF

Rationale & Objective: Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are novel, orally administered agents for anemia management in chronic kidney disease (CKD). We evaluated the cardiac and kidney-related adverse effects of HIF-PHIs among patients with CKD and anemia.

Study Design: Systematic review and meta-analysis of randomized controlled trials (RCTs).

View Article and Find Full Text PDF

Chronic kidney disease (CKD) is a global public health issue. In recent years, the effectiveness of finerenone for treatment of CKD has been the subject of considerable debate. The main objective of the current meta-analysis was to validate the clinical efficacy and safety of finerenone in patients with CKD.

View Article and Find Full Text PDF

Membranous nephropathy (MN) is an organ-restricted autoimmune disease mainly caused by circulating autoantibodies against podocyte antigens, including the M-type phospholipase A2 receptor (PLA2R) and thrombospondin domain-containing 7A (THSD7A). Antibodies against PLA2R are present in 70%-80% and against THSD7A in 2% of adult patients, which provides a paradigm shift in molecular diagnosis and management monitoring. Both antigens share some similar characteristics: they are expressed by podocytes and have wide tissue distributions; they are bound by autoantibodies only under nonreducing conditions, and the subtype of most autoantibodies is IgG4.

View Article and Find Full Text PDF

Introduction: Controlled ovarian hyperstimulation (COH) is the routine regimen used to generate a sufficient number of follicles during in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatment. Poor ovarian response is a challenge encountered by many clinicians during COH and poor ovarian responders (PORs) usually have higher follicle stimulating hormone levels, lower levels of anti-Mullerian hormone and few oocytes retrieved, which have been attributed mainly to advanced maternal age and poor follicle reserve or other reasons that could impair ovarian response during ovarian stimulation. Over the last few decades, researchers have proposed a series of strategies and ovarian stimulation protocols to improve pregnancy outcomes in patients with POR during their IVF/ICSI treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Daprodustat is an oral treatment for anemia related to chronic kidney disease (CKD), and a systematic review compared its effectiveness and safety to rhEPO and placebo in patients with CKD.
  • The review included eight studies with 1,516 participants, finding that daprodustat significantly improved hemoglobin levels over placebo in both dialysis-dependent and non-dialysis-dependent patients, with similar effectiveness compared to rhEPO.
  • Safety results indicated no significant difference in serious adverse events between daprodustat and placebo, and fewer incidents in the daprodustat group compared to rhEPO, suggesting daprodustat is a promising alternative for treating anemia in CKD.
View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is an increasing public health issue. Anemia, which is a complication of CKD, is associated with reduced quality of life and increased morbidity and mortality. Currently quite a few clinical studies have been conducted to compare roxadustat with epoetin alfa [all for dialysis-dependent (DD) patients] or placebo [all for nondialysis-dependent (NDD) patients].

View Article and Find Full Text PDF
Article Synopsis
  • HIF-PHIs are new oral medications designed to treat anemia in patients with chronic kidney disease (CKD) who are not on dialysis, compared against epoetin and darbepoetin.
  • A review of 19 clinical trials showed that all HIF-PHIs, except for vadadustat, significantly increased hemoglobin levels compared to placebo, with no notable differences in efficacy among them.
  • Additionally, there were no significant associations found between these medications and all-cause mortality, indicating they are effective and relatively safe for this patient group, although further research is needed.
View Article and Find Full Text PDF

We systematically studied the characteristics of hybrid perovskite-based surface plasmon nanolasers. If one changes the anion composition of perovskites, the emission wavelength can be easily tuned. We conducted in full-spectrum modeling that featured hybrid perovskite nanowires placed on different SiO-coated metallic (Au, Ag, and Al) plates.

View Article and Find Full Text PDF

Objective: This study is aimed at investigating the efficacy of a very low-energy diet (VLED) in overweight and obese individuals with type 2 diabetes mellitus (T2DM).

Methods: We thoroughly searched eight electronic resource databases of controlled studies concerning the efficacy and acceptability of intermittent or continuous VLEDs in patients with T2DM compared with other energy restriction interventions.

Results: Eighteen studies (11 randomized and seven nonrandomized controlled trials) with 911 participants were included.

View Article and Find Full Text PDF

Objectives: This study aimed to compare the effectiveness of 13 types of immunosuppressive agents used to treat idiopathic membranous nephropathy (IMN) in adults with nephrotic syndrome.

Design: Systematic review and network meta-analysis.

Data Sources: PubMed, EMbase, Cochrane Library, Web of Science, Clinical trials, SinoMed, Chinese Biomedicine, CNKI, WanFang and Chongqing VIP Information databases were comprehensively searched until February 2018.

View Article and Find Full Text PDF

The incidence of idiopathic membranous nephropathy (IMN) is increasing year by year, and the clinical research on Chinese medicine treatment of INM is also growing. This study aims to evaluate the efficiency and safety of Yiqi Huoxue method for IMN. Data sources used were from PubMed, EMbase, the Cochrane Library, CBM, CNKI, Wanfang and VIP database.

View Article and Find Full Text PDF